ECSP972325A - INHIBITING AMIDES OF THE APO B / MTP SECRETION - Google Patents

INHIBITING AMIDES OF THE APO B / MTP SECRETION

Info

Publication number
ECSP972325A
ECSP972325A ECSP972325A ECSP972325A EC SP972325 A ECSP972325 A EC SP972325A EC SP972325 A ECSP972325 A EC SP972325A EC SP972325 A ECSP972325 A EC SP972325A
Authority
EC
Ecuador
Prior art keywords
inhibitors
compounds
hmg
useful
apo
Prior art date
Application number
Other languages
Spanish (es)
Inventor
George Chang
John A Hey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972325 priority Critical patent/ECSP972325A/en
Publication of ECSP972325A publication Critical patent/ECSP972325A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

El invento se refiere a un compuesto de la fórmula I (gráfico), o a los estereosómeros, sales farmacéuticamente aceptables e hidratos de los mismos. Los compuestos son inhibidores de Apo B/MTP y son útiles en el tratamiento de diversos trastornos y afecciones tales como la aterosclerosis, la pancreatitis, la obesidad, la hipercolesterolemia, la hipertrigliceridemia, la hiperlipidemia y la diabetis. Los compuestos de esta invención también son útiles junto con otros agentes farmacéuticos que incluyen inhibidores de la biosíntesis de colesterol e inhibidores de la absorción de colesterol, especialmente inhibidores de la absorción de colesteril, especialmente inhibidores de la HMG-CoA reductasa e inhibidores de la HMG - CoA sintasa; inhibidores de la expresión genética de la HMG-CoA reductasa; inhibidores de CETP; complejantes de ácidos bilares; fibratos; inhibidores de la absorción del colesterol; inhibidores de ACT, inhibidores de la escualeno sintetasa, resinas de intercambio iónico, antioxidantes y niacina. Esta invención también está dirigida a intermedios y procedimientos útiles en la preparación de compuestos de fórmula I.The invention relates to a compound of formula I (graph), or to stereosomers, pharmaceutically acceptable salts and hydrates thereof. The compounds are Apo B / MTP inhibitors and are useful in the treatment of various disorders and conditions such as atherosclerosis, pancreatitis, obesity, hypercholesterolemia, hypertriglyceridemia, hyperlipidemia, and diabetes. The compounds of this invention are also useful in conjunction with other pharmaceutical agents including cholesterol biosynthesis inhibitors and cholesterol absorption inhibitors, especially cholesteryl absorption inhibitors, especially HMG-CoA reductase inhibitors and HMG inhibitors. - CoA synthase; inhibitors of HMG-CoA reductase gene expression; CETP inhibitors; bile acid complexing agents; fibrates; cholesterol absorption inhibitors; ACT inhibitors, squalene synthetase inhibitors, ion exchange resins, antioxidants and niacin. This invention is also directed to intermediates and procedures useful in the preparation of compounds of formula I.

ECSP972325 1997-11-27 1997-11-27 INHIBITING AMIDES OF THE APO B / MTP SECRETION ECSP972325A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972325 ECSP972325A (en) 1997-11-27 1997-11-27 INHIBITING AMIDES OF THE APO B / MTP SECRETION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972325 ECSP972325A (en) 1997-11-27 1997-11-27 INHIBITING AMIDES OF THE APO B / MTP SECRETION

Publications (1)

Publication Number Publication Date
ECSP972325A true ECSP972325A (en) 1998-12-14

Family

ID=42043154

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972325 ECSP972325A (en) 1997-11-27 1997-11-27 INHIBITING AMIDES OF THE APO B / MTP SECRETION

Country Status (1)

Country Link
EC (1) ECSP972325A (en)

Similar Documents

Publication Publication Date Title
AR010309A1 (en) INHIBITING COMPOUNDS OF THE APO B / MTP SECRETION, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCEDURE FOR THEIR PREPARATION
PT1140184E (en) COMBINATIONS OF ESTER TRANSFER PROTEIN INHIBITORS OF CHOLESTEROL WITH NICOTINIC ACID DERIVATIVES FOR CARDIOVASCULAR INDICATIONS
WO1998040375A3 (en) COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS
TW200736221A (en) Novel pharmaceutical salts and polymorphs of a Factor Xa inhibitor
DE60301491D1 (en) Acc-hemmer
BR9916565A (en) Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
MXPA02012415A (en) HMG-CoA REDUCTASE INHIBITORS AND METHOD.
MXPA02012252A (en) HMG-CoA REDUCTASE INHIBITORS AND METHOD.
IL148014A0 (en) Cell adhesion inhibitors
AU7756694A (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
TW200745052A (en) Thyroid hormone receptor agonists
PT882707E (en) NEW TRICYLIC COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
MX2007007187A (en) (5s) -3-[(s)-fluoro (4-trifluoromethylphenyl) methyl]-5,6,7,8-tetrahydroquinoline-5-ol derivatives and use thereof as cetp inhibitors.
MX9702175A (en) Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor.
GB9816935D0 (en) Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders
MXPA05009611A (en) SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS.
UA99109C2 (en) Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
EP0773022A3 (en) Pharmaceutical composition for the treatment of rhinitus, containing sympathomometic and pantothenol and/or pantothenic acid
BR0307801A (en) Process for the manufacture of hmg-coa reductase inhibitors mevalic acid derivatives
DK0895981T3 (en) New Terphenyl Compounds and Medicines Containing These Compounds
ECSP972325A (en) INHIBITING AMIDES OF THE APO B / MTP SECRETION
MXPA01006469A (en) Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications.
ATE228520T1 (en) LACTAM COMPOUNDS AS CHOLESTEROL ESTERASE INHIBITORS
CO4650034A1 (en) INHIBITING AMIDES OF THE APO B / MTP SECRETION
HK1137011A1 (en) Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives